chr1-219915334-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_018713.3(SLC30A10):c.*115C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000853 in 1,317,174 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0041 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 1 hom. )
Consequence
SLC30A10
NM_018713.3 3_prime_UTR
NM_018713.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.109
Genes affected
SLC30A10 (HGNC:25355): (solute carrier family 30 member 10) This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-219915334-G-C is Benign according to our data. Variant chr1-219915334-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 874880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC30A10 | NM_018713.3 | c.*115C>G | 3_prime_UTR_variant | 4/4 | ENST00000366926.4 | NP_061183.2 | ||
SLC30A10 | NM_001376929.1 | c.*115C>G | 3_prime_UTR_variant | 4/4 | NP_001363858.1 | |||
SLC30A10 | NM_001416004.1 | c.*115C>G | 3_prime_UTR_variant | 3/3 | NP_001402933.1 | |||
SLC30A10 | NM_001416005.1 | c.*115C>G | 3_prime_UTR_variant | 4/4 | NP_001402934.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC30A10 | ENST00000366926.4 | c.*115C>G | 3_prime_UTR_variant | 4/4 | 1 | NM_018713.3 | ENSP00000355893 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00413 AC: 628AN: 152206Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
628
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000423 AC: 493AN: 1164850Hom.: 1 Cov.: 16 AF XY: 0.000377 AC XY: 219AN XY: 581346
GnomAD4 exome
AF:
AC:
493
AN:
1164850
Hom.:
Cov.:
16
AF XY:
AC XY:
219
AN XY:
581346
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00414 AC: 630AN: 152324Hom.: 4 Cov.: 33 AF XY: 0.00399 AC XY: 297AN XY: 74486
GnomAD4 genome
AF:
AC:
630
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
297
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hypermanganesemia with dystonia, polycythemia, and cirrhosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at